CEACAM5 and hepatocellular carcinoma: The high rate of CEA-positive hepatocellular carcinomas described in several previous studies is likely due to the use of less specific and/or polyclonal CEA antibodies, which leads to positivity rates between 15–100% [30,47,48,49].